Quince Therapeutics Inc - Rasio total nilai perusahaan marang pendapatan QNCX

Quince Therapeutics (QNCX) - logo korporat

Global logistics risks and trade barriers are exerting external pressure on Quince Therapeutics. This chart on GURU.Markets illustrates how the company's EV/Sales multiple is reacting to these challenges, while the 0.00 metric confirms the current level. Business stability relies on innovative erythrocyte-based drug delivery, although the lack of operating cash flow leaves the company dependent on existing capital reserves.

QNCX Quince Therapeutics, Inc.: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 12.10.2026

Rincian metrik keuangan lan pasar Quince Therapeutics (QNCX)

- rega saham lan prakiraan rega para ahli:
- indikator dhuwit lan arus kas:
Pambiji fundamental perusahaan:QNCX (Quince)
Produk mawa merek Quince

Geopolitical tensions and sanction barriers are hindering the clinical trials of Quince Therapeutics (QNCX), making the analysis of operational efficiency critical. The company's EV/Sales valuation compares the total enterprise value, including debt, with generated revenue, allowing investors to determine the extent of the premium paid for the asset. A decrease in this ratio indicates growing fundamental stability of the stock, limiting the risks of a further collapse in market capitalization.

Analisis pesaing

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|AGIO - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan GPCR|Multiplikator nilai perusahaan marang pendapatan MiMedx MDXG|Rasio nilai perusahaan marang pendapatan Rezolute Corp (RZLT)|Nilai perusahaan marang pendapatan Lexicon Corp LXRX|Rasio nilai perusahaan marang pendapatan MBX Biosciences, Inc. MBX|Multiplikator EV/Sales altimmune.com ALT|AARD - Rasio nilai perusahaan marang pendapatan|Sagimet - Koefisien nilai perusahaan marang pendapatan|BioAge Labs Inc. (BIOA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang volume dodolan BMEA (Biomea Fusion, Inc.)|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)